Equities research analysts at StockNews.com started coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) in a research report issued on Tuesday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Price Performance Shares of NASDAQ INO opened at $0.38 on Tuesday. The stock has a market capitalization of […]
StockNews.com assumed coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a report released on Monday. The firm issued a hold rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Price Performance INO stock opened at $0.38 on Monday. The business has a 50 day simple moving average of $0.41 and a 200-day simple […]
Keystone Financial Group acquired a new stake in shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) in the second quarter, HoldingsChannel.com reports. The fund acquired 106,397 shares of the biopharmaceutical company’s stock, valued at approximately $48,000. Other institutional investors and hedge funds also recently bought and sold shares of the company. Legal & General […]
StockNews.com assumed coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) in a research note issued to investors on Monday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Price Performance Shares of Inovio Pharmaceuticals stock opened at $0.40 on Monday. The business has a 50-day simple moving average […]
StockNews.com began coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a research note published on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Price Performance INO opened at $0.58 on Friday. The company has a market capitalization of $151.21 million, a price-to-earnings ratio of -0.59 […]